MFF
BMRN icon

Michels Family Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Michels Family Financial’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Sell
4,068
-120
-3% -$7K 0.17% 127
2025
Q4 		$249K Sell
4,188
-430
-9% -$23.4K 0.18% 125
2025
Q3 		$250K Buy
+4,618
New +$264K 0.19% 122

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Michels Family Financial's BMRN Position: Q1 2026 in Review

Michels Family Financial reduced its BioMarin Pharmaceuticals (BMRN) stake by 2.9% in Q1 2026, selling an estimated $7K and leaving 4,068 shares worth $230K. The position accounts for 0.17% of the portfolio, ranked #127.

Michels Family Financial first reported a position in BMRN in Q3 2025 and has held it in 3 quarters since. The position peaked at $250K in Q3 2025. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Michels Family Financial held 4,068 shares of BioMarin Pharmaceuticals worth $230K as of Q1 2026.
  • Michels Family Financial sold 120 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $7K.
  • BioMarin Pharmaceuticals made up 0.17% of Michels Family Financial's portfolio in Q1 2026, its #127 holding.
  • Michels Family Financial first reported a position in BioMarin Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Michels Family Financial's BioMarin Pharmaceuticals position peaked at $250K in Q3 2025.
  • 555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Michels Family Financial's 13F filing for Q1 2026, filed 24 Apr 2026.